Atlas Trials

Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Clinical trial NCT01304160 · COMPLETED

Trial details

NCT number
NCT01304160
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic CancerUnresectable Pancreatic Cancer
Start date
2010-09-01
Primary completion
2016-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.